The pharma executive is optimistic about the new US administration but is also realistic about the risks that come with "radical change." ...
Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...
Pfizer’s chief executive said he was “disappointed” with Robert F Kennedy Jr’s refusal to disavow the debunked link between vaccines and autism, even as he expressed confidence that the Trump ...
Trump has not yet outlined specific health policy plans ... I guess we'll see," Pfizer CEO Albert Bourla said during a ...
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Despite last week’s Arctic blast, a buoyancy filled the air as if spring had arrived after a four-year freeze. U.S.
CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing transformative changes.’ ...